HFCAS OpenIR

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
Authors:  Lu, S.;  Jian, H.;  Zhang, Y.;  Song, Z.;  Zhao, Y.;  Wang, P.;  Jiang, L.;  Gong, Y.;  Zhou, J.;  Dong, X.;  Yang, N.;  Fang, J.;  Zhuang, W.;  Cang, S.;  Ma, R.;  Shi, J.;  Wu, P.;  Lu, J.;  Xiang, Z.;  Shi, Z.;  Zhang, L.;  Wang, Y.
Favorite  |  View/Download:61/0  |  Submit date:2022/12/23
Non-small cell lung cancer  KRAS G12C mutation  Small molecular inhibitor  
A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
Authors:  Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S.;  Cheng, Y.;  Wu, G.;  Cao, P.;  Lv, D.;  Jian, H.;  Chen, C.;  Jin, X.;  Tian, P.;  Wang, K.;  Jiang, G.;  Chen, G.;  Chen, Q.;  Zhao, H.;  Ding, C.;  Guo, R.;  Sun, G.;  Wang, B.;  Jiang, L.;  Liu, Z.;  Fang, J.;  Yang, J.;  Zhuang, W.;  Liu, Y.;  Zhang, J.;  Pan, Y.;  Chen, J.;  Yu, Q.;  Zhao, M.;  Cui, J.;  Li, D.;  Yi, T.;  Yu, Z.;  Yang, Y.;  Zhang, Y.;  Zhi, X.;  Huang, Y.;  Wu, R.;  Chen, L.;  Zang, A.;  Cao, L.;  Li, Q.;  Li, X.;  Song, Y.;  Wang, D.;  Zhang, S.
Favorite  |  View/Download:41/0  |  Submit date:2022/12/23
third-generation EGFR-TKI  befotertinib  T790M  
ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
Authors:  Cheng, Y.;  Wang, J.;  Cang, S.;  Cao, L.;  Chen, E.;  Dong, X.;  Fan, Y.;  Gao, B.;  Guo, Q.;  Huang, D.;  Li, S.;  Liu, A.;  Lv, D.;  Pan, Y.;  Tang, K.;  Yao, W.;  Ye, F.;  Yu, Y.;  Zang, A.;  Gao, M.
Favorite  |  View/Download:55/0  |  Submit date:2021/04/26